How to Find Cheap Stocks that’ll Earn you 1,000% Gains

I discovered this movement after a trip to... [Energy and Capital Header] Practical Investment Analysis for the New Energy Economy How to Find Cheap Stocks that’ll Earn you 1,000% Gains Jeff Siegel | Apr 26, 2024 If you’re looking for cheap stocks to buy now, you’ve come to the right place. Because the truth is, I’ve made an entire career out of discovering undervalued stocks, buying them on the cheap, then riding them to the top. [cheap stocks to buy now] A stock can be undervalued for many reasons: - Poor earnings cause a stock to become oversold, falling below its intrinsic value. - A private placement priced at a significant discount allows for an opening to buy a stock at a discount. Although these tend to happen rather quickly and require quick and decisive action. - A stock operating within a burgeoning industry showing significant growth potential but is not being covered, or is simply not being properly valued by the Wall Street elite. It’s the latter where I’ve made the lion’s share of my biggest winners. New Oil Drilling Innovation Unlocks Texas-Size Profit Potential Nestled in Texas' Permian Basin is a secret that’s about to turn the oil industry on its head... A small firm has developed a new drilling method that puts fracking to shame. It could DOUBLE domestic oil production and transform America into the world’s No. 1 oil superpower. [See the full story behind this firm’s breakthrough "Horseshoe Well."]( Consider Tesla (NASDAQ: TSLA), for instance. While the stock has struggled over the past few years, it made huge gains in the first eleven years, following its IPO.  I had actually been covering the EV sector all the way back in 2006. I was meeting with insiders, battery manufacturers, and even spoke at a number of investment conferences about this new industry that would soon prove to be one of the most disruptive things to happen to the automobile market since the first Model T rolled off the line in 1908. Of course, I was met with a lot of pushback, and even a fair amount of hate mail. But I stuck to my guns. And I’m glad I did. Those who followed my advice and bought shares of Tesla right after it went public made a fortune. Before the stock started selling off, some were up in excess of 19,000%. That’s not a misprint. [newteslachart] A similar thing happened when I started singing the praises of the legal cannabis industry. An industry that really hadn’t received much coverage at all, despite a legalization movement that was taking hold in Canada. I discovered this movement after a trip to Toronto to visit an old colleague. He made his fortune in the fracking boom, and then expanded that fortune after taking part in a couple of early pre-IPO rounds for a handful of Canadian cannabis stocks. So I did a bit of digging and realized something very big was about to happen. I extended my trip in Canada, visited a couple of cannabis growing operations, and met with a few lawmakers who had the inside scoop on a new legalization bill. It was clear to me that Canada would soon legalize the recreational use of cannabis, and I was certain that such an event would send these stocks — which were really penny stocks at the time — to the moon. I recommended to my readers that they buy shares of three cannabis stocks: - Aphria, Inc. (TSX: APH) - OrganiGram Holdings (TSX-V:OGI) - Canopy Growth Corporation (TSX-WEED) All three absolutely crushed it. We landed a 1,174% gain on Aphria, a 1,185% gain on OrganiGram, and a 3,015% gain on Canopy Growth Corporation.  To put this in perspective, a one-time investment of $10,000 in Canopy Growth turned into $311,500 in less than three years. That’s more than a quarter of a million dollars. From one single undervalued and super cheap stock. Now I’m not writing to you today just to chest pound. Instead, I’m writing to you to let you know that I have a new opportunity for you to get in on a few deals that I believe will deliver the same types of gains we saw from Tesla and Canopy Growth Corporation. Biden's New Law Triggers a Lithium Frenzy(This $5 Stock Could Explode) President Biden has taken decisive steps to jump-start domestic lithium mining and production. Under the Inflation Reduction Act, he's earmarked a massive $369 BILLION for EV and battery companies. But to qualify for the full credit, vehicles must have at least 50% of their battery metals sourced from North America by 2024... And this requirement DOUBLES to 100% by 2029. As a result, automakers are scrambling to secure their lithium supply within the U.S. This strategy not only aims to reduce U.S. reliance on Chinese lithium... But it also turns a hidden American caldera into the center of a new lithium mining age... Containing up to 120 megatons of lithium, not only does it dwarf all other known deposits worldwide by a substantial margin... But it will also allow the U.S. to fulfill its future lithium demands and achieve complete energy independence. And there's a little-known publicly traded company already leading this lithium-rich caldera. This company exclusively owns a land area as large as Martha’s Vineyard... And it’s estimated to contain 19 million tons of lithium... That’s worth a staggering $354 BILLION. This amount is more than enough to meet the global demand for over a decade! In just a few months, the company plans to start extracting 40,000 tons of lithium annually. One that could easily support the production of 1 million EVs every year. You can buy shares for just $5 right now — but not for long... [Click here for all the details before it's too late.]( More Cheap Stocks to Buy Now Last month, I told you about something called EN-23.  EN-23 represents a valuable class of molecules that drastically improves brain function. It’s actually one of the biggest breakthroughs medical science has seen in 50 years. Not only can it treat mental health conditions such as depression, anxiety, PTSD and addiction, it also has the ability to help you lose weight, treat chronic pain and even extend your lifespan by up to 20 years. The profit potential of EN-23 is massive. But similar to what we saw with cannabis, most EN-23 medications are not approved by the government. So naturally, institutional money has largely ignored it. Until now. You see, on August 11th, we expect the very first EN-23 medication to be approved by the FDA. We got word on this last month. And shortly after that announcement, we discovered that J.P. Morgan (the behemoth investment bank with assets valued in excess of $2.5 trillion), had decided to start meeting with a number of companies developing new EN-23 treatments for mental health conditions. Since then, the value of my three favorite EN-23 stocks has soared.  I already told you about one of them: MindMed (NASDAQ: MNMD). Here’s how that stock has performed over the past six months … [newmnmdchart] But mark my words: once the FDA approves the first EN-23 medication sold in the U.S., these other EN-23 stocks are going to the moon. Which is why I put together this new investment report on [my favorite EN-23 Stocks to buy before August 11th.]( These ARE undervalued stocks. They are, without a doubt, the next cheap stocks to buy now. So unless you hate money, I highly recommend you get some of this action for yourself. While I may not always be the smartest person in the room, I know how to find — and profit from — undervalued stocks. And those who follow my advice tend to make a lot of money in the process. If you don’t believe me, just [look at the numbers for yourself]( To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]Check us out on YouTube!]( [[follow basic]@JeffSiegel on Twitter]( Jeff is the founder and managing editor of Green Chip Stocks. For more on Jeff, go to his editor's [page](. Want to hear more from Jeff? [Sign up to receive emails directly from him]( ranging from market commentaries to opportunities that he has his eye on. [Fb]( [Li]( [Tw]( This email was sent to {EMAIL}. You can manage your subscription and get our privacy policy [here](. Energy and Capital, Copyright © 3 East Read Street, Baltimore, MD 21202. Please note: It is not our intention to send email to anyone who doesn't want it. If you're not sure why you're getting this e-letter, or no longer wish to receive it, get more info [here]( including our privacy policy and information on how to manage your subscription. If you are interested in our other publications, please call our customer service team at [1-877-303-4529](tel:/18773034529).